HeartSciences Stock Quote HSCS - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

3.50

Bid

3.36

Ask

3.57

Volume

7,106

3.35 Day's Range 3.565

2.36 52 Week Range 18.50

Market Cap

3.431M

Previous Close

3.45

Open

3.46

Last Trade

3.36

Last Trade Time

16:00:00

Financial Volume

$ 24,440

VWAP

3.4393

Average Volume (3m)

36,861

Shares Outstanding

980,321

Dividend Yield

PE Ratio

-0.52

Earnings Per Share (EPS)

-6.74

Revenue

19k

Net Profit

-6.61M

Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-o... Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. Show more

Sector

Ortho,prosth,surg Appl,suply

Industry

Ortho,prosth,surg Appl,suply

Website

www.heartsciences.com

Headquarters

Southlake, Texas, USA

Founded

HeartSciences Inc is listed in the Ortho,prosth,surg Appl,suply sector of the NASDAQ with ticker HSCS. The last closing price for HeartSciences was $3.45. Over the last year, HeartSciences shares have traded in a share price range of $ 2.36 to $ 18.50.

HeartSciences currently has 980,321 shares outstanding. The market capitalization of HeartSciences is $3.38 million. HeartSciences has a price to earnings ratio (PE ratio) of -0.52.

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Southlake, TX, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company...

HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

Southlake, TX, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

Southlake, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

Southlake, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Southlake, TX, July 29, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

Southlake, TX, July 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

Southlake, TX, July 25, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

Southlake, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Regains Compliance with Nasdaq Listing Requirements

Southlake, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	3.5	3.57	3.2411	10323	3.40133407	CS
4	-0.01	-0.2849002849	3.51	4.0799	3.1	18124	3.57644647	CS
12	0.56	19.0476190476	2.94	4.6902	2.5164	36861	3.48849752	CS
26	-0.2	-5.40540540541	3.7	5.2989	2.36	199931	4.02083254	CS
52	-8.5	-70.8333333333	12	18.5	2.36	916915	10.72766296	CS
156	-371.5	-99.0666666667	375	600	2.36	1701304	77.20315253	CS
260	-371.5	-99.0666666667	375	600	2.36	1701304	77.20315253	CS

HSCS - Frequently Asked Questions (FAQ)

What is the current HeartSciences share price?

The current share price of HeartSciences is $ 3.50

How many HeartSciences shares are in issue?

HeartSciences has 980,321 shares in issue

What is the market cap of HeartSciences?

The market capitalisation of HeartSciences is USD 3.38M

What is the 1 year trading range for HeartSciences share price?

HeartSciences has traded in the range of $ 2.36 to $ 18.50 during the past year

What is the PE ratio of HeartSciences?

The price to earnings ratio of HeartSciences is -0.52

What is the cash to sales ratio of HeartSciences?

The cash to sales ratio of HeartSciences is 180.41

What is the reporting currency for HeartSciences?

HeartSciences reports financial results in USD

What is the latest annual turnover for HeartSciences?

The latest annual turnover of HeartSciences is USD 19k

What is the latest annual profit for HeartSciences?

The latest annual profit of HeartSciences is USD -6.61M

What is the registered address of HeartSciences?

The registered address for HeartSciences is 550 RESERVE ST, SUITE 360, SOUTHLAKE, TEXAS, 76092

What is the HeartSciences website address?

The website address for HeartSciences is www.heartsciences.com

Which industry sector does HeartSciences operate in?

HeartSciences operates in the ORTHO,PROSTH,SURG APPL,SUPLY sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DGNXDiginex Ltd	12.00 (65.29%)	525.45k
XCURExicure Inc	$ 15.997 (55.92%)	274.47k
TLSATiziana Life Sciences Ltd	$ 0.9297 (16.50%)	1.18M
IVAInventiva SA	$ 2.3996 (10.58%)	2.87k
SNESSenesTech Inc	$ 3.3168 (9.47%)	1k
ASTSAST SpaceMobile Inc	$ 20.47 (-9.10%)	366.77k
SHPHShuttle Pharmaceuticals Holdings Inc	$ 0.928 (-8.12%)	248.11k
BLBXBlackBoxStocks Inc	$ 5.14 (-7.05%)	894.27k
EAElectronic Arts Inc	$ 133.00 (-6.55%)	254.05k
PRAXPraxis Precision Medicines Inc	$ 74.75 (-5.94%)	252.54k
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.319 (-0.03%)	10.92M
RIMEAlgorhythm Holdings Inc	$ 0.0331 (0.00%)	2.29M
KOPNKopin Corporation	$ 1.60 (8.12%)	1.64M
TLSATiziana Life Sciences Ltd	$ 0.9341 (17.06%)	1.18M
NVDANVIDIA Corporation	$ 146.86 (-0.12%)	1.17M